De-Risk Early or Pay Later

Download this free infographic to learn more.

Selecting a development candidate is one of the most expensive decisions in drug discovery, and it is often made before there is enough data to make it well.

This infographic shows how Evotec helps biotech and pharma teams make that decision on better evidence, and then act on it quickly:

INDiGO-Select: a focused de-risking assessment that surfaces DMPK, safety and developability liabilities while they are still inexpensive to fix
Stop, rework or confirm: how assessment findings become a clear go/no-go decision, not a longer report
INDiGO: an integrated route from nominated candidate to IND, with one team accountable for the critical path
New Approach Methodologies: where predictive science fits early to strengthen the decision

Download the infographic to see the full framework and the decision points at each stage.

FILL THE FORM BELOW

First Name *

Last Name *

Company Street Address *

Company Suite/Office *

Company Postal/Zip Code *

Company City *

Company State *

Company Country *

By submitting this content request, I have legitimate interest in the content and agree that Evotec International GmbH, their partners, and the creators of any other content I have selected may contact me regarding news, products, and services that may be of interest to me.

YesNo

I acknowledge and agree to the use of my contact information to receive messages about offerings by Questex, its brands, affiliates and/or third-party partners, consistent with Questex Privacy Policy